Synthesis and biological evaluation of novel benzothiazole-2-thiol derivatives as potential anticancer agents. 2012

Xuan-Hong Shi, and Zhao Wang, and Yong Xia, and Ting-Hong Ye, and Mei Deng, and You-Zhi Xu, and Yu-Quan Wei, and Luo-Ting Yu
State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, China.

A series of novel benzothiazole-2-thiol derivatives were synthesized and their structures determined by 1H-NMR, 13C-NMR and HRMS (ESI). The effects of all compounds on a panel of different types of human cancer cell lines were investigated. Among them, pyridinyl-2-amine linked benzothiazole-2-thiol compounds 7d, 7e, 7f and 7i exhibited potent and broad-spectrum inhibitory activities. Compound 7e displayed the most potent anticancer activity on SKRB-3 (IC(50) = 1.2 nM), SW620 (IC(50) = 4.3 nM), A549 (IC(50) = 44 nM) and HepG2 (IC(50) = 48 nM) and was found to induce apoptosis in HepG2 cancer cells.

UI MeSH Term Description Entries
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D052160 Benzothiazoles Compounds with a benzene ring fused to a thiazole ring.

Related Publications

Xuan-Hong Shi, and Zhao Wang, and Yong Xia, and Ting-Hong Ye, and Mei Deng, and You-Zhi Xu, and Yu-Quan Wei, and Luo-Ting Yu
January 2024, Frontiers in chemistry,
Xuan-Hong Shi, and Zhao Wang, and Yong Xia, and Ting-Hong Ye, and Mei Deng, and You-Zhi Xu, and Yu-Quan Wei, and Luo-Ting Yu
February 2016, Molecules (Basel, Switzerland),
Xuan-Hong Shi, and Zhao Wang, and Yong Xia, and Ting-Hong Ye, and Mei Deng, and You-Zhi Xu, and Yu-Quan Wei, and Luo-Ting Yu
January 2007, Arzneimittel-Forschung,
Xuan-Hong Shi, and Zhao Wang, and Yong Xia, and Ting-Hong Ye, and Mei Deng, and You-Zhi Xu, and Yu-Quan Wei, and Luo-Ting Yu
September 2012, Bioorganic & medicinal chemistry letters,
Xuan-Hong Shi, and Zhao Wang, and Yong Xia, and Ting-Hong Ye, and Mei Deng, and You-Zhi Xu, and Yu-Quan Wei, and Luo-Ting Yu
August 2021, Bioorganic & medicinal chemistry letters,
Xuan-Hong Shi, and Zhao Wang, and Yong Xia, and Ting-Hong Ye, and Mei Deng, and You-Zhi Xu, and Yu-Quan Wei, and Luo-Ting Yu
June 2023, Fitoterapia,
Xuan-Hong Shi, and Zhao Wang, and Yong Xia, and Ting-Hong Ye, and Mei Deng, and You-Zhi Xu, and Yu-Quan Wei, and Luo-Ting Yu
March 2024, ACS omega,
Xuan-Hong Shi, and Zhao Wang, and Yong Xia, and Ting-Hong Ye, and Mei Deng, and You-Zhi Xu, and Yu-Quan Wei, and Luo-Ting Yu
March 2021, Bioorganic chemistry,
Xuan-Hong Shi, and Zhao Wang, and Yong Xia, and Ting-Hong Ye, and Mei Deng, and You-Zhi Xu, and Yu-Quan Wei, and Luo-Ting Yu
June 2021, Bioorganic chemistry,
Xuan-Hong Shi, and Zhao Wang, and Yong Xia, and Ting-Hong Ye, and Mei Deng, and You-Zhi Xu, and Yu-Quan Wei, and Luo-Ting Yu
April 2010, European journal of medicinal chemistry,
Copied contents to your clipboard!